1. Briefings from international organizations on their work on the public health element of the world drug problem p.3
2. Principles for prioritizing and assessing substances as part of ECDD’s work p.10
3. Update from the first Informal Working Group of the ECDD p.11

4. Follow-up on recommendations made by the ECDD at its thirty-seventh meeting p.12
4.1 Acetylfentanyl
4.2 MT-45
4.3 para-Methoxymethylamphetamine (PMMA)
4.4 α-Pyrrolidinovalerophenone (α-PVP)
4.5 para-Methyl-4-methylaminorex (4,4´-DMAR)
4.6 Methoxetamine (MXE)
47 Phenazepam

5. Critical review of psychoactive substances p.14
5.1 U-47700
5.2 Butyrfentanyl (butyrylfentanyl)
5.3 4-Methylethcathinone (4-MEC)
5.4 3-Methylmethcathinone (3-methyl-N-methylcathinone; 3-MMC)
5.5 Ethylone (3,4-methylenedioxy-N-ethylcathinone; bk-MDEA; MEDEC)
5.6 Pentedrone (α-methylaminovalerophenone)
5.7 Ethylphenidate (EPH)
5.8 Methiopropamine (MPA)
5.9 MDMB-CHMICA
5.10 5F-APINACA (5F-AKB-48)
5.11 JWH-073
5.12 XLR-11

6. Updates p.35
7. Follow-up on recommendations from international meetings and consultations p.37
8. Future agenda items p.42